[L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow].
D000208:Acute Disease; D000367:Age Factors; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007680:Kidney Neoplasms / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D013160:Splenic Neoplasms / Q000188:drug therapy; D013997:Time Factors
D001215:Asparaginase; D011241:Prednisone
L-asparaginaza w skojarzonym leczeniu pozaszpikowych umiejscowień ostrej białaczki u dzieci